📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: APIRx

1.1 - Company Overview

APIRx Logo

APIRx

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cGMP cannabinoid APIs based on naturally extracted cannabinoids, and cannabinoid-infused products including CBD pet food, wellness gum, CBD roll-on sticks, cannabinoid suppositories, and cannabinoid chewing gum potentially combined with other active ingredients like nicotine.

Products and services

  • Cannabinoid APIs: APIRx engineers cGMP-compliant active pharmaceutical ingredients based on naturally extracted cannabinoids, as a cGMP cannabis plant user and provider of cGMP APIs
  • Cannabinoid Chewing Gum: APIRx architects nicotine-compatible chewing gum infused with cannabinoids, potentially combined with other active ingredients like nicotine for cannabinoid delivery
  • Cannabinoid Suppositories: APIRx constructs targeted-delivery suppositories containing cannabinoids, developed for targeted delivery and therapeutic effects in cannabinoid administration

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to APIRx

NutraLife BioSciences Logo

NutraLife BioSciences

HQ: United States Website
  • Description: Provider of nutraceutical and wellness products and private label manufacturing/labeling for other companies, including raw materials, production, and shipping. Offers hemp-derived, non-psychoactive CBD (NutraHempCBD), phytocannabinoid-rich PCR Pure, Eddie's Clean Hands sanitizers (70% alcohol, aloe), Eddie's Immune Boost, and Invisipatch bug-repellent patches. Uses high-quality, tested ingredients with certificates of analysis and U.S.-vetted hemp.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NutraLife BioSciences company profile →
Sire Bioscience Logo

Sire Bioscience

HQ: Canada Website
  • Description: Provider of mid-sized cannabis production, using less water and space to deliver more predictable product outcomes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sire Bioscience company profile →
MMJ International Holdings Logo

MMJ International Holdings

HQ: United States Website
  • Description: Provider of pharmaceutical-grade cannabinoid formulations, including extended-release THC/CBD capsules for neurological disorders, supported by clinical trials focused on Multiple Sclerosis and Huntington's Disease. Services include DEA-compliant cannabis cultivation and extraction, educational programs for healthcare professionals, and eHealth solutions for remote monitoring, telemedicine, and patient care.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MMJ International Holdings company profile →
Hash Logo

Hash

HQ: Canada Website
  • Description: Provider of cannabis-based products specializing in authentic, traditional hashish experiences. Delivers nostalgic hashish products; modern applications of ancient trichome separation and finishing techniques; selective breeding of heirloom hash-specific cultivars with licensed farmers; innovative cannabis resin product development; and the Hash Kettle device for traditional hashish inhalation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hash company profile →
MPX Bioceutical Logo

MPX Bioceutical

HQ: Canada Website
  • Description: Provider of medical marijuana and pharma-grade products, with a mission to become a leading commercial producer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MPX Bioceutical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for APIRx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to APIRx

2.2 - Growth funds investing in similar companies to APIRx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for APIRx

4.2 - Public trading comparable groups for APIRx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to APIRx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About APIRx

What does APIRx do?

APIRx is a provider of cGMP cannabinoid APIs based on naturally extracted cannabinoids, and cannabinoid-infused products including CBD pet food, wellness gum, CBD roll-on sticks, cannabinoid suppositories, and cannabinoid chewing gum potentially combined with other active ingredients like nicotine.

Who are APIRx's competitors?

APIRx's competitors and similar companies include NutraLife BioSciences, Sire Bioscience, MMJ International Holdings, Hash, and MPX Bioceutical.

Where is APIRx headquartered?

APIRx is headquartered in United States.

How many employees does APIRx have?

APIRx has 1,000 employees 🔒.

When was APIRx founded?

APIRx was founded in 2010 🔒.

What sector and industry vertical is APIRx in?

APIRx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for APIRx

Who are the top strategic acquirers in APIRx's sector and industry

Top strategic M&A buyers and acquirers in APIRx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for APIRx?

Top strategic M&A buyers groups and sectors for APIRx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in APIRx's sector and industry vertical

Which are the top PE firms investing in APIRx's sector and industry vertical?

Top PE firms investing in APIRx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in APIRx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in APIRx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in APIRx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to APIRx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in APIRx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for APIRx?

The key public trading comparables and valuation benchmarks for APIRx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for APIRx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for APIRx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in APIRx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for APIRx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in APIRx's' sector and industry vertical?

Access recent funding rounds and capital raises in APIRx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for APIRx